In situ photoimmunotherapy: a tumour-directed treatment for melanoma. (Q33263668)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17107404%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

In situ photoimmunotherapy: a tumour-directed treatment for melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17107404%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17107404%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

M F Naylor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17107404%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

W R Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17107404%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

L A Perry

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17107404%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

R E Nordquist

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17107404%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17107404%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Dermatology

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17107404%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

155

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17107404%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17107404%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

1287-1292

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17107404%20AND%20SRC:MED&resulttype=core&format=json

A new American Joint Committee on Cancer staging system for cutaneous melanoma

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07514.X

Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07514.X

Long-term tumor resistance induced by laser photo-immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07514.X

Induced antitumor immunity against DMBA‐4 metastatic mammary tumors in rats using laser immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07514.X

In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07514.X

Imiquimod, pegylated interferon-alpha-2b and interleukin-2 in the treatment of cutaneous melanoma metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07514.X

Management of cutaneous locoregional recurrences of melanoma: a new therapeutic perspective with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07514.X

Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07514.X

Locoregional cutaneous metastases of malignant melanoma and their management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07514.X

Modulating vaccine responses with dendritic cells and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07514.X

Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07514.X

Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07514.X

Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07514.X

CpG motifs are efficient adjuvants for DNA cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07514.X

Immunological foundations to the quest for new vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07514.X